Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Miller

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|August 30, 2021
ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic PropertiesNicole Pribut, Michael D'Erasmo, Madhuri Dasari, et al.
ACS Pharmacology & Translational Science|May 18, 2023
Discovery of 5'-Substituted 5-Fluoro-2'-deoxyuridine Monophosphate Analogs: A Novel Class of Thymidylate Synthase InhibitorsMadhuri Dasari, Stephen C Pelly, Jiafeng Geng, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of <i>N</i>-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like PropertiesYesim A Tahirovic, Valarie M Truax, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters|January 20, 2018
Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 AntagonistsRobert J Wilson, Edgars Jecs, Eric J Miller, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-ChainsEdgars Jecs, Eric J Miller, Robert J Wilson, et al.
Journal of Medicinal Chemistry|July 28, 2018
Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME PropertiesHuy H Nguyen, Michelle B Kim, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor PropertiesEric J Miller, Suzanne G Mays, Mark T Baillie, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald CouplingsHuy H Nguyen, Yesim A Tahirovic, Valarie M Truax, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron IncorporationHannah Beth Gold, Nicole Pribut, Esther L Outtrim, et al.
Journal of Medicinal Chemistry|April 6, 2026
Discovery of Novel 2-Morpholine Tetrahydroisoquinoline CXCR4 Antagonists with Unique PropertiesYesim Altas Tahirovic, Zafer Sahin, Edgars Jecs, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|August 30, 2021
ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic PropertiesNicole Pribut, Michael D'Erasmo, Madhuri Dasari, et al.
ACS Pharmacology & Translational Science|May 18, 2023
Discovery of 5'-Substituted 5-Fluoro-2'-deoxyuridine Monophosphate Analogs: A Novel Class of Thymidylate Synthase InhibitorsMadhuri Dasari, Stephen C Pelly, Jiafeng Geng, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of <i>N</i>-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like PropertiesYesim A Tahirovic, Valarie M Truax, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters|January 20, 2018
Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 AntagonistsRobert J Wilson, Edgars Jecs, Eric J Miller, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-ChainsEdgars Jecs, Eric J Miller, Robert J Wilson, et al.
Journal of Medicinal Chemistry|July 28, 2018
Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME PropertiesHuy H Nguyen, Michelle B Kim, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor PropertiesEric J Miller, Suzanne G Mays, Mark T Baillie, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald CouplingsHuy H Nguyen, Yesim A Tahirovic, Valarie M Truax, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron IncorporationHannah Beth Gold, Nicole Pribut, Esther L Outtrim, et al.
Journal of Medicinal Chemistry|April 6, 2026
Discovery of Novel 2-Morpholine Tetrahydroisoquinoline CXCR4 Antagonists with Unique PropertiesYesim Altas Tahirovic, Zafer Sahin, Edgars Jecs, et al.
Pageof 6